Xr Securities LLC Provention Bio, Inc. Transaction History

Xr Securities LLC

  • $342 Million
  • Q3 2024

A detailed history of Xr Securities LLC transactions in Provention Bio, Inc. stock. As of the latest transaction made, Xr Securities LLC holds 25,000 shares of PRVB stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,000
Holding current value
$0
% of portfolio
0.02%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email